Document is current
Any future updates will be listed below
-
Authors
Haddad, Alexander F.
Saha, Atul https://orcid.org/0009-0009-9411-9881
Collins, Sara A.
Lovalvo, Isabella https://orcid.org/0009-0000-3805-431X
Gill, Sabraj
Montoya, Megan L.
Shukla, Poojan
Hong, Jinpyo https://orcid.org/0009-0004-9256-9233
Wang, Elaina
Chuntova, Pavlina
Lad, Meeki
Osorio, Robert https://orcid.org/0000-0002-7669-2176
Chen, Jia-Shu
Sathavipat, Melissa https://orcid.org/0009-0002-2114-2094
Jain, Saket
Chalif, Eric
Kasahara, Noriyuki https://orcid.org/0000-0002-9186-911X
Aghi, Manish K. https://orcid.org/0000-0002-2949-2227
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS079697)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (5UE5NS070680-15)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA260443)
- License Information
-
More Information
Article History
Received: 13 February 2025
Accepted: 21 April 2026
First Online: 19 May 2026
Competing interests
: M.K.A., N.K., A.F.H., and S.C. are co-founders and consultants for Kopra Bio, a startup company founded in summer 2024 based on the work presented in this manuscript. S.C. is an employee of 4D Molecular Therapeutics. M.S. is an employee of Kopra Bio. The remaining authors declare no competing interests.
